The Study
Discordance Between Thyroid Function and Thyroid-Stimulating Hormone (TSH) Receptor Antibodies in Down Syndrome Patients With Autoimmune Thyroid Disease: A Long-Term Follow-Up Study of Two Cases
This study is like writing about two kids with a weird thyroid problem and saying, 'Hey, look at what happened to them!' It doesn't prove that this happens to other kids or why it happens—it just shows two examples.
Analysis score
Maximum 30 for a case report.
Where the score came from
Some kids with Down syndrome and thyroid problems have antibodies that usually make the thyroid overactive, but their thyroid still sometimes stops working — even when those antibodies are still present.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 530 / 100
Quality score
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — this means doctors can't just rely on antibody tests to decide if a patient needs medicine; they must watch how the patient feels and how thyroid hormone levels change over time.
- 2Two kids had positive TSAb antibodies (which should cause hyperthyroidism) but still developed hypothyroidism.
- 3One had episodes of hyperthyroidism that got better on their own without medicine.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Cureus
Year
2025
Authors
Yuki Shibagaki, Shigeru Suzuki, A. Furuya, Takahide Kokumai, Satoru Takahashi
Related Content
Claims (6)
Antibodies that bind to thyroid-stimulating hormone receptors lead to increased thyroid hormone levels and hyperthyroidism.
In people with Down syndrome and Hashimoto thyroiditis, the simultaneous presence of two specific antibodies at diagnosis is followed by a change in disease type to Graves disease, showing that changes in antibody levels determine the clinical outcome.
In people with Down syndrome and autoimmune thyroid disease, hypothyroidism can occur even when the thyroid-stimulation blocking antibody is absent, as long as the thyroid-stimulating antibody is present, indicating that the blocking antibody is not required for hypothyroidism to develop.
In people with Down syndrome and autoimmune thyroid disease, the presence of thyroid-stimulating antibodies does not lead to normal thyroid function even when blocking antibodies are absent, because chronic inflammation has damaged the thyroid follicles.
People with Down syndrome and autoimmune thyroid disease experience repeated shifts between overactive and underactive thyroid states over many years, even after stopping thyroid medication, making their condition difficult to manage.
Some people with Down syndrome and autoimmune thyroid disease experience a temporary overactive thyroid with specific antibodies, and this condition resolves on its own without medication, indicating it is Hashitoxicosis and not Graves disease, even when the antibody pattern resembles Graves disease.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.